{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:41:13Z","timestamp":1789180873487,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2257,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"German Society for Research","award":["BA-5158\/1-1"],"award-info":[{"award-number":["BA-5158\/1-1"]}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/jth.13405","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T01:57:01Z","timestamp":1467683821000},"page":"1685-1695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Protamine (heparin)\u2010induced thrombocytopenia: a review of the serological and clinical features associated with anti\u2010protamine\/heparin antibodies"],"prefix":"10.1016","volume":"14","author":[{"given":"T.","family":"Bakchoul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Warkentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13405_bb0010","doi-asserted-by":"crossref","first-page":"e24376","DOI":"10.4161\/spmg.24376","article-title":"Protamines and spermatogenesis in Drosophila and Homo sapiens : A comparative analysis","volume":"3","author":"Kanippayoor","year":"2013","journal-title":"Spermatogenesis"},{"key":"10.1111\/jth.13405_bb0015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11239-008-0280-4","article-title":"Anticoagulant therapy during cardiopulmonary bypass","volume":"26","author":"Yavari","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.13405_bb0020","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/dia.2008.0019","article-title":"The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart: a randomized, glucose clamp, crossover study","volume":"10","author":"Heise","year":"2008","journal-title":"Diabetes Technol Ther"},{"key":"10.1111\/jth.13405_bb0025","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1213\/00000539-198309000-00010","article-title":"Hemodynamic changes during protamine administration","volume":"62","author":"Michaels","year":"1983","journal-title":"Anesth Analg"},{"key":"10.1111\/jth.13405_bb0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF02802312","article-title":"Allergy to protamine","volume":"9","author":"Weiss","year":"1991","journal-title":"Clin Rev Allergy"},{"key":"10.1111\/jth.13405_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0091-6749(90)90189-B","article-title":"A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery","volume":"85","author":"Weiler","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/jth.13405_bb0040","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0735-1097(98)00484-7","article-title":"Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass","volume":"32","author":"Kimmel","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.13405_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF01991461","article-title":"Histamine release from rat mast cells induced by protamine sulfate and polyethylene imine","volume":"11","author":"Schnitzler","year":"1981","journal-title":"Agents Actions"},{"key":"10.1111\/jth.13405_bb0050","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0022-5223(19)38449-1","article-title":"Protamine\u2010induced circulatory changes","volume":"87","author":"Frater","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.13405_bb0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0049-3848(80)90207-8","article-title":"Interaction of C1s and C1 inactivator in the presence of heparin, dextran sulfate and protamine sulfate","volume":"18","author":"Takada","year":"1980","journal-title":"Thromb Res"},{"key":"10.1111\/jth.13405_bb0060","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-5223(97)70197-1","article-title":"Complement activation by heparin\u2010protamine complexes during cardiopulmonary bypass: effect of C4A null allele","volume":"114","author":"Shastri","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.13405_bb0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4049\/jimmunol.114.1_Part_1.120","article-title":"Complement activation by interaction of polyanions and polycations. I. Heparin\u2010protamine induced consumption of complement","volume":"114","author":"Rent","year":"1975","journal-title":"J Immunol"},{"key":"10.1111\/jth.13405_bb0070","first-page":"525","article-title":"Evidence for complement activation by protamine\u2010heparin interaction after cardiopulmonary bypass","volume":"98","author":"Cavarocchi","year":"1985","journal-title":"Surgery"},{"key":"10.1111\/jth.13405_bb0075","first-page":"252","article-title":"Studies on the immunogenicity of protamines in humans and experimental animals by means of a micro\u2010complement fixation test","volume":"33","author":"Samuel","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/jth.13405_bb0080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/diab.37.2.172","article-title":"Frequency and specificity of protamine antibodies in diabetic and control subjects","volume":"37","author":"Nell","year":"1988","journal-title":"Diabetes"},{"key":"10.1111\/jth.13405_bb0085","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0038-1661237","article-title":"Protamine\u2010induced thrombocytopenia and leukopenia","volume":"53","author":"Al\u2010Mondhiry","year":"1985","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0090","first-page":"277","article-title":"Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non\u2010diabetic patients","volume":"61","author":"Gottschlich","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1111\/jth.13405_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.70.5.788","article-title":"Increased risk of severe protamine reactions in NPH insulin\u2010dependent diabetics undergoing cardiac catheterization","volume":"70","author":"Stewart","year":"1984","journal-title":"Circulation"},{"key":"10.1111\/jth.13405_bb0100","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1182\/blood-2010-06-292938","article-title":"Heparin modifies the immunogenicity of positively charged proteins","volume":"116","author":"Chudasama","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0105","first-page":"A65","article-title":"Association of protamine sulfate antibodies with \u2018Pseudo\u2010HIT\u2019 in heparin treated patients","volume":"PP4.4\u20139","author":"Amiral","year":"2009","journal-title":"Haemostaseologie"},{"key":"10.1111\/jth.13405_bb0110","series-title":"53rd American Society of Hematology Annual Meeting and Exposition","article-title":"Incidence of antibodies to protamine\/heparin complexes in cardiac surgery patients and impact on platelet activation in vitro and clinical outcome","author":"Pouplard","year":"2011"},{"key":"10.1111\/jth.13405_bb0115","article-title":"Anti\u2010protamine sulphate\/heparin antibodies can activate platelets and may cause thrombocytopenia in patients undergoing cardiac surgery","volume":"9","author":"Bakchoul","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0120","first-page":"247","article-title":"Heparin\u2010associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4\u2010heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0125","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.athoracsur.2003.09.034","article-title":"Heparin\u2010induced thrombocytopenia and cardiac surgery","volume":"76","author":"Warkentin","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jth.13405_bb0130","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2012-10-460691","article-title":"Anti\u2010protamine\u2010heparin antibodies: incidence, clinical relevance, and pathogenesis","volume":"121","author":"Bakchoul","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0135","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1160\/TH12-11-0844","article-title":"Incidence of antibodies to protamine sulfate\/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome","volume":"109","author":"Pouplard","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0140","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1182\/blood-2012-11-469130","article-title":"High incidence of antibodies to protamine and protamine\/heparin complexes in patients undergoing cardiopulmonary bypass","volume":"121","author":"Lee","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1515\/cclm-2014-0664","article-title":"Serological features of antibodies to protamine inducing thrombocytopenia and thrombosis","volume":"53","author":"Panzer","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1111\/jth.13405_bb0150","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1111\/trf.12112","article-title":"Protamine\u2010induced immune thrombocytopenia","volume":"53","author":"Singla","year":"2013","journal-title":"Transfusion"},{"key":"10.1111\/jth.13405_bb0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin\u2010induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0160","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13405_bb0165","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2007-08-105098","article-title":"Determinants of PF4\/heparin immunogenicity","volume":"110","author":"Suvarna","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A diagnostic test for heparin\u2010induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0175","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2015.07.057","article-title":"Platelet\u2010activating protamine\u2010heparin\u2010antibodies lead to higher protamine demand in patients undergoing cardiac surgery","volume":"150","author":"Grieshaber","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1111\/jth.13405_bb0180","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V124.21.2784.2784","article-title":"Biologic Activities of Protamine\/Heparin Antibodies. 56th ASH Annual Meeting and Exposition. 2014","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0185","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin\u2010induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13405_bb0190","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","article-title":"Serological investigation of patients with a previous history of heparin\u2010induced thrombocytopenia who are reexposed to heparin","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0195","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1365-2141.2005.05381.x","article-title":"Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin\u2010dependent antibodies","volume":"128","author":"Pouplard","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.13405_bb0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1445-2197.1995.tb00648.x","article-title":"Heparin\u2010rebound in the early postoperative phase following cardiopulmonary bypass","volume":"65","author":"Subramaniam","year":"1995","journal-title":"Aust N Z J Surg"},{"key":"10.1111\/jth.13405_bb0205","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1160\/th15-07-0539","article-title":"Partially desulfated heparin modulates the interaction between anti\u2010protamine\/heparin antibodies and platelets","volume":"115","author":"Jouni","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0210","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/jth.13003","article-title":"Heparin enhances uptake of platelet factor 4\/heparin complexes by monocytes and macrophages","volume":"13","author":"Joglekar","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13405_bb0215","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1182\/blood.V93.5.1622","article-title":"Labeling of the internal pool of GP IIb\u2010IIIa in platelets by c7E3 Fab fragments (abciximab): flow and endocytic mechanisms contribute to the transport","volume":"93","author":"Nurden","year":"1999","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0220","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1182\/blood-2009-02-203034","article-title":"Megakaryocyte impairment by eptifibatide\u2010induced antibodies causes prolonged thrombocytopenia","volume":"114","author":"Greinacher","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13405_bb0225","first-page":"3","article-title":"Platelet destruction in immune thrombocytopenia. Understanding the mechanisms","volume":"35","author":"Bakchoul","year":"2015","journal-title":"Hamostaseologie"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13405","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13405","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13405\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:15:06Z","timestamp":1761534906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622035693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1538783622035693"],"URL":"https:\/\/doi.org\/10.1111\/jth.13405","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protamine (heparin)\u2010induced thrombocytopenia: a review of the serological and clinical features associated with anti\u2010protamine\/heparin antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}